Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. T 3762
2. T-3762
1. 163680-77-1
2. Pazufloxacin Mesilate
3. Pazufloxacin Methanesulfonate
4. Pazucross
5. Pasil
6. Pazufloxaxin Methanesulfonate
7. Pazufloxacin (mesylate)
8. 2xi226j1hs
9. T-3762
10. Pazufloxacinmesylate
11. Nsc-759831
12. (2s)-6-(1-aminocyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic Acid;methanesulfonic Acid
13. Pazufloxacin Mesylate 100 Microg/ml In Acetonitrile
14. (2s)-6-(1-aminocyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13),11-tetraene-11-carboxylic Acid; Methanesulfonic Acid
15. Unii-2xi226j1hs
16. T 3762
17. Mfcd00913262
18. Pasil (tn)
19. Pazufloxacin Mesilate (jp17)
20. Schembl4442183
21. Hy-b0724a
22. Dtxsid80167645
23. Hms3264i18
24. Pharmakon1600-01502319
25. Pazufloxacin Mesilate [jan]
26. Amy18115
27. Bcp11980
28. Nsc759831
29. S3621
30. Pazufloxacin Mesilate [mart.]
31. Akos015852496
32. Akos015895384
33. Pazufloxacin Mesilate [who-dd]
34. Ccg-213820
35. Cs-4497
36. Gm-1172
37. Nsc 759831
38. Pazufloxacin Methanesulfonate [mi]
39. P1962
40. D05382
41. 045p414
42. Q-101928
43. Q27255767
44. Pazufloxacin Mesilate, Vetranal(tm), Analytical Standard
45. Pazufloxacinamesilate, Antibiotic For Culture Media Use Only
46. (-)-(3s)-10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid Methanesulfonate
47. (-)-(3s)-10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid Methanesulphonate
48. (s)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid Compound With Methanesulfonic Acid (1:1)
49. (s)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2h-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid Methanesulfonic Acid Salt
50. 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (s)-, Monomethanesulfonate
51. 7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3s)-, Methanesulfonate (1:1)
Molecular Weight | 414.4 g/mol |
---|---|
Molecular Formula | C17H19FN2O7S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 2 |
Exact Mass | 414.08970028 g/mol |
Monoisotopic Mass | 414.08970028 g/mol |
Topological Polar Surface Area | 156 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 695 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
68
PharmaCompass offers a list of Pazufloxacin Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pazufloxacin Mesylate manufacturer or Pazufloxacin Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pazufloxacin Mesylate manufacturer or Pazufloxacin Mesylate supplier.
PharmaCompass also assists you with knowing the Pazufloxacin Mesylate API Price utilized in the formulation of products. Pazufloxacin Mesylate API Price is not always fixed or binding as the Pazufloxacin Mesylate Price is obtained through a variety of data sources. The Pazufloxacin Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pazufloxacin Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pazufloxacin Mesylate, including repackagers and relabelers. The FDA regulates Pazufloxacin Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pazufloxacin Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pazufloxacin Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pazufloxacin Mesylate supplier is an individual or a company that provides Pazufloxacin Mesylate active pharmaceutical ingredient (API) or Pazufloxacin Mesylate finished formulations upon request. The Pazufloxacin Mesylate suppliers may include Pazufloxacin Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Pazufloxacin Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pazufloxacin Mesylate Drug Master File in Korea (Pazufloxacin Mesylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pazufloxacin Mesylate. The MFDS reviews the Pazufloxacin Mesylate KDMF as part of the drug registration process and uses the information provided in the Pazufloxacin Mesylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pazufloxacin Mesylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pazufloxacin Mesylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pazufloxacin Mesylate suppliers with KDMF on PharmaCompass.
Pazufloxacin Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pazufloxacin Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pazufloxacin Mesylate GMP manufacturer or Pazufloxacin Mesylate GMP API supplier for your needs.
A Pazufloxacin Mesylate CoA (Certificate of Analysis) is a formal document that attests to Pazufloxacin Mesylate's compliance with Pazufloxacin Mesylate specifications and serves as a tool for batch-level quality control.
Pazufloxacin Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Pazufloxacin Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pazufloxacin Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pazufloxacin Mesylate EP), Pazufloxacin Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pazufloxacin Mesylate USP).